To examine the functionality of Ctbp1-KO T cells, and to test our hypothesis, we determined their tumor-killing capacity and effector phenotype after 3 weeks chronic tumor-antigen stimulation in vitro. The gene discussed is CTBP1; the disease is neoplasm.